IPO Amicus Brief in Amgen Inc., et al. v. Sanofi, et al., 21-757
IPO Amicus Brief in Amgen Inc., et al. v. Sanofi, [...]
IPO Amicus Brief in Amgen Inc., et al. v. Sanofi, [...]
IPO Amicus Brief in Abitron Austria Gmbh V. Hetronic International, [...]
IPO Comments to CNIPA on Draft Revised Patent Examination Guidelines
A FRESH NEW LOOK FOR THE AWARDS CELEBRATION ON DECEMBER [...]
IPO Comments in Response to USPTO Regarding Director Review
IPO Comments to USPTO Regarding Subject Matter Eligibility Guidance
IPO Comments to USTR Regarding Notorious Markets Review
IPO Comments Regarding Proposed Rulemaking Pertaining to Patent Term Adjustment
IPO and Other Associations Joint Statement of Support For Existing [...]
IPO Responses to EU Questionnaire Regarding Compulsory Licensing